SACCOMANO NICHOLAS A (President and CEO) sold 0.8% of their position (87.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $258.76 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/23/2026ACC: 0001609284-26-000005
DirectorOfficer· President and CEO
Since Oct 2024
-87.00
Net shares
Net seller
$258.76
Total sold
1
Open market trades
0B · 1S
1
Total transactions
87.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−87.00
Price / share
$2.97
Trade value
$258.76
% of position
0.8%
9/21/2026
11.25K→11.16K
Total
Net shares
−87.00
Net value
-$258.76
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/21/2026 | S · Sale | −87.00 | $2.97 | $258.76 | 0.8% | 11.25K | 11.16K |
| Total | −87.00 | -$258.76 | ||||||
Derivative Transactions0
No derivative transactions reported